Management of Post-Urethral Sling Overactive Bladder Symptoms

Diagnostic Evaluation

The American Urological Association recommends a combination of frequency, nocturia, and pelvic pain after urethral sling placement demands urgent investigation for device-related problems before treating as simple overactive bladder 1, 2, 3
Cystoscopy is necessary to evaluate for mesh erosion into the urethra or bladder, which can present with irritative voiding symptoms and pelvic pain rather than classic signs of infection 1, 2
Post-void residual measurement is required to assess for urinary retention or incomplete emptying from sling-induced obstruction 4
Review of the operative report is essential to determine sling type, location, and tension applied during placement 3
Urodynamic studies may be necessary if the distinction between outlet obstruction and detrusor overactivity remains unclear after initial evaluation 5

Complete sling explantation is required if mesh erosion or infection is identified 1, 2, 3
A urethral catheter should be left in place for several weeks to allow healing 1, 3
It is recommended to wait 3-6 months before considering replacement device 1, 3
Sling revision or takedown may be necessary if elevated post-void residual or urodynamic evidence of obstruction is present 3

The American Urological Association recommends antimuscarinic agents as the primary treatment for OAB symptoms including urgency, frequency, and nocturia 4
Alternative antimuscarinics, such as oxybutynin, tolterodine, or trospium, can be used if solifenacin is not tolerated 4
Beta-3 adrenergic agonists, such as mirabegron, are an alternative first-line option 4

Bladder training with scheduled voiding intervals is recommended 4
Fluid management, including avoiding excessive intake, particularly before bedtime for nocturia, is necessary 4
Caffeine reduction is recommended 4
Pelvic floor muscle training may be complicated by prior sling placement, but can still be beneficial 4

Sling explantation should be discussed if symptoms remain refractory to all medical and neuromodulation therapies and quality of life is severely impaired 1, 3
The morbidity of persistent OAB symptoms and pelvic pain should be weighed against the risk of recurrent stress incontinence after sling removal 1, 6